Add Yahoo as a preferred source to see more of our stories on Google. Avtar Dhillon is pictured on his farm in Abbotsford, B.C., on Oct. 30. (Ethan Cairns/CBC - image credit) As golden hour settles ...

DR. AVTAR DHILLON joined Genetronics Biomedical Corporation as President and Chief Executive Officer in September 2001 and a Director in October 2001. Prior to joining the company, Dr. Dhillon was ...

DR. AVTAR DHILLON joined Genetronics Biomedical Corporation as President and Chief Executive Officer in September 2001 and a Director in October 2001. Prior to joining the company, Dr. Dhillon was ...

BLUE BELL, Pa., July 1, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, ...

VICTORIA, British Columbia, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced today that Dr. Avtar Dhillon, Executive ...

Life science company Arch Therapeutics has appointed Dr. Avtar Dhillon as board chair and Dr. Arthur Rosenthal as director. The company has also appointed Dr. Terrence W. Norchi as president & CEO.

VANCOUVER, May 17 - Qwest Bancorp has launched the Qwest Emerging Biotech (VCC) Fund Ltd. The members of the Qwest's Emerging Biotech (VCC) Fund investment committee are chairman Jim Heppell and Dr.

Approach: Delivers electrical pulse to the surface of a tumor and injects DNA into the cancerous cells. The gene triggers production of IL-12 protein, which targets and destroys cancer cells. Stock: ...

As golden hour settles over Avtar Dhillon’s farm in Abbotsford, B.C., rows of delicate purple flowers are in full bloom. Inside their petals grow crimson threads of the world’s most expensive spice — ...